Meta-analyses have robustly demonstrated that CD8+ T-cells are associated with improved survival in CRC, and this is likely due to clonal expansion of tumour antigen-specific CD8+ T-cells which support an anti-tumour immune response [34,35]. The gene discussed is CD8A; the disease is colorectal carcinoma.